{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T03:39:27Z","timestamp":1781494767784,"version":"3.54.1"},"reference-count":43,"publisher":"The Endocrine Society","issue":"5","license":[{"start":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T00:00:00Z","timestamp":1639440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100005089","name":"Beijing Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["7214246"],"award-info":[{"award-number":["7214246"]}],"id":[{"id":"10.13039\/501100005089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFA0800801"],"award-info":[{"award-number":["2018YFA0800801"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970757"],"award-info":[{"award-number":["81970757"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Excessive production of fibroblast growth factor 23 (FGF23) by a tumor is considered the main pathogenesis in tumor-induced osteomalacia (TIO). Despite its importance to comprehensive understanding of pathogenesis and diagnosis, the regulation of systemic metabolism in TIO remains unclear.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>We aimed to systematically characterize the metabolome alteration associated with TIO.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>By means of liquid chromatography\u2013tandem mass spectrometry\u2013based metabolomics, we analyzed the metabolic profile from 96 serum samples (32 from TIO patients at initial diagnosis, pairwise samples after tumor resection, and 32 matched healthy control (HC) subjects). In order to screen and evaluate potential biomarkers, statistical analyses, pathway enrichment and receiver operating characteristic (ROC) were performed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Metabolomic profiling revealed distinct alterations between TIO and HC cohorts. Differential metabolites were screened and conducted to functional clustering and annotation. A significantly enriched pathway was found involving arachidonic acid metabolism. A combination of 5 oxylipins, 4-HDoHE, leukotriene B4, 5-HETE, 17-HETE, and 9,10,13-TriHOME, demonstrated a high sensitivity and specificity panel for TIO prediction screened by random forest algorithm (AUC\u2005=\u20050.951; 95% CI, 0.827-1). Supported vector machine modeling and partial least squares modeling were conducted to validate the predictive capabilities of the diagnostic panel.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Metabolite profiling of TIO showed significant alterations compared with HC. A high-sensitivity and high-specificity panel with 5 oxylipins was tested as diagnostic predictor. For the first time, we provide the global profile of metabolomes and identify potential diagnostic biomarkers of TIO. The present work may offer novel insights into the pathogenesis of TIO.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgab885","type":"journal-article","created":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T12:08:21Z","timestamp":1639483701000},"page":"1383-1391","source":"Crossref","is-referenced-by-count":6,"title":["Serum Metabolomics Reveals Dysregulation and Diagnostic Potential of Oxylipins in Tumor-induced Osteomalacia"],"prefix":"10.1210","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5400-9524","authenticated-orcid":false,"given":"Yiyi","family":"Gong","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Commission of Health, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China"},{"name":"Medical Research Center, National Commission of Health, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Ni","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Commission of Health, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Commission of Health, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Commission of Health, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Wang","sequence":"additional","affiliation":[{"name":"Medical Research Center, National Commission of Health, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ou","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Commission of Health, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Commission of Health, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Xing","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Commission of Health, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Wu","sequence":"additional","affiliation":[{"name":"Medical Research Center, National Commission of Health, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Commission of Health, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7768-5536","authenticated-orcid":false,"given":"Weibo","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Commission of Health, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2021,12,14]]},"reference":[{"key":"2022041907513249300_CIT0001","doi-asserted-by":"crossref","first-page":"17044","DOI":"10.1038\/nrdp.2017.44","article-title":"Tumour-induced osteomalacia","volume":"3","author":"Minisola","year":"2017","journal-title":"Nat Rev Dis Primers."},{"issue":"1","key":"2022041907513249300_CIT0002","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s00223-020-00691-6","article-title":"Tumor-induced osteomalacia","volume":"108","author":"Florenzano","year":"2021","journal-title":"Calcif Tissue Int."},{"issue":"9","key":"2022041907513249300_CIT0003","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/jbmr.1642","article-title":"Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: Report of 39 cases and review of the literature","volume":"27","author":"Jiang","year":"2012","journal-title":"J Bone Miner Res."},{"issue":"3","key":"2022041907513249300_CIT0004","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/jbmr.3903","article-title":"Nonremission and recurrent tumor-induced osteomalacia: a retrospective study","volume":"35","author":"Li","year":"2020","journal-title":"J Bone Miner Res."},{"issue":"1","key":"2022041907513249300_CIT0005","first-page":"33","article-title":"Osteomalacia with Looser\u2019s nodes (Milkman\u2019s syndrome) due to a raised resistance to vitamin D acquired about the age of 15 years","volume":"16","author":"McCance","year":"1947","journal-title":"Q J Med."},{"issue":"4","key":"2022041907513249300_CIT0006","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/path.4465","article-title":"Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour","volume":"235","author":"Lee","year":"2015","journal-title":"J Pathol."},{"issue":"11","key":"2022041907513249300_CIT0007","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/modpathol.2016.137","article-title":"Characterization of FN1-FGFR1 and novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors","volume":"29","author":"Lee","year":"2016","journal-title":"Mod Pathol."},{"issue":"7216","key":"2022041907513249300_CIT0008","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/4551054a","article-title":"Systems biology: Metabonomics","volume":"455","author":"Nicholson","year":"2008","journal-title":"Nature."},{"issue":"5","key":"2022041907513249300_CIT0009","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11306-018-1354-8","article-title":"Predicting ovarian cancer recurrence by plasma metabolic profiles before and after surgery","volume":"14","author":"Zhang","year":"2018","journal-title":"Metabolomics."},{"issue":"8","key":"2022041907513249300_CIT0010","doi-asserted-by":"crossref","first-page":"529","DOI":"10.21037\/atm.2020.04.03","article-title":"Metabolomic alterations associated with Kallmann syndrome","volume":"8","author":"Guo","year":"2020","journal-title":"Ann Transl Med."},{"issue":"7929","key":"2022041907513249300_CIT0011","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(75)92736-1","article-title":"Nomogram for derivation of renal threshold phosphate concentration","volume":"2","author":"Walton","year":"1975","journal-title":"Lancet."},{"key":"2022041907513249300_CIT0012","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bone.2013.11.008","article-title":"A compound heterozygous mutation in SLC34A3 causes hereditary hypophosphatemic rickets with hypercalciuria in a Chinese patient","volume":"59","author":"Chi","year":"2014","journal-title":"Bone."},{"key":"2022041907513249300_CIT0013","article-title":"Supplementary Materials for Serum metabolomics reveals dysregulation and diagnostic potential of oxylipins in tumor-induced osteomalacia","author":"Gong","year":"2021"},{"issue":"15","key":"2022041907513249300_CIT0014","doi-asserted-by":"crossref","first-page":"8102","DOI":"10.3390\/ijms22158102","article-title":"Inflammation, extracellular matrix remodeling, and proteostasis in tumor microenvironment","volume":"22","author":"Marozzi","year":"2021","journal-title":"Int J Mol Sci."},{"issue":"5","key":"2022041907513249300_CIT0015","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3945\/an.114.007732","article-title":"Advances in our understanding of oxylipins derived from dietary PUFAs","volume":"6","author":"Gabbs","year":"2015","journal-title":"Adv Nutr."},{"issue":"1","key":"2022041907513249300_CIT0016","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1172\/JCI200113416","article-title":"Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes","volume":"108","author":"Tilley","year":"2001","journal-title":"J Clin Invest."},{"issue":"3","key":"2022041907513249300_CIT0017","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.immuni.2014.02.009","article-title":"Proresolving lipid mediators and mechanisms in the resolution of acute inflammation","volume":"40","author":"Buckley","year":"2014","journal-title":"Immunity."},{"issue":"6","key":"2022041907513249300_CIT0018","doi-asserted-by":"crossref","first-page":"e98459","DOI":"10.1172\/jci.insight.98459","article-title":"Enzymatically oxidized phospholipids restore thrombin generation in coagulation factor deficiencies","volume":"3","author":"Slatter","year":"2018","journal-title":"JCI Insight."},{"issue":"507","key":"2022041907513249300_CIT0019","doi-asserted-by":"crossref","first-page":"eaan2787","DOI":"10.1126\/scisignal.aan2787","article-title":"Networks of enzymatically oxidized membrane lipids support calcium-dependent coagulation factor binding to maintain hemostasis","volume":"10","author":"Lauder","year":"2017","journal-title":"Sci Signal."},{"key":"2022041907513249300_CIT0020","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.freeradbiomed.2019.05.012","article-title":"MS-based targeted metabolomics of eicosanoids and other oxylipins: analytical and inter-individual variabilities","volume":"144","author":"Gladine","year":"2019","journal-title":"Free Radic Biol Med."},{"key":"2022041907513249300_CIT0021","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3389\/fphar.2019.01147","article-title":"Oxidized lipids in persistent pain states","volume":"10","author":"Osthues","year":"2019","journal-title":"Front Pharmacol."},{"issue":"3","key":"2022041907513249300_CIT0022","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10555-020-09904-8","article-title":"Role of linoleic acid-derived oxylipins in cancer","volume":"39","author":"Edin","year":"2020","journal-title":"Cancer Metastasis Rev."},{"key":"2022041907513249300_CIT0023","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3389\/fphar.2020.00828","article-title":"Expression and function of eicosanoid-producing cytochrome P450 enzymes in solid tumors","volume":"11","author":"Evangelista","year":"2020","journal-title":"Front Pharmacol."},{"key":"2022041907513249300_CIT0024","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev.iy.02.040184.002003","article-title":"The role of arachidonic acid oxygenation products in pain and inflammation","volume":"2","author":"Davies","year":"1984","journal-title":"Annu Rev Immunol."},{"issue":"3","key":"2022041907513249300_CIT0025","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/oxfordjournals.jbchem.a003101","article-title":"Phospholipase A2","volume":"131","author":"Murakami","year":"2002","journal-title":"J Biochem."},{"issue":"44","key":"2022041907513249300_CIT0026","doi-asserted-by":"crossref","first-page":"18820","DOI":"10.1073\/pnas.0905415106","article-title":"Activation of TRPV1 in the spinal cord by oxidized linoleic acid metabolites contributes to inflammatory hyperalgesia","volume":"106","author":"Patwardhan","year":"2009","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"2","key":"2022041907513249300_CIT0027","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3390\/ijms18020236","article-title":"Cross-talk between cancer cells and the tumour microenvironment: the role of the 5-lipoxygenase pathway","volume":"18","author":"Moore","year":"2017","journal-title":"Int J Mol Sci."},{"issue":"6917","key":"2022041907513249300_CIT0028","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature."},{"issue":"1","key":"2022041907513249300_CIT0029","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1006\/bbrc.1999.1012","article-title":"Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells","volume":"261","author":"Ding","year":"1999","journal-title":"Biochem Biophys Res Commun."},{"issue":"1","key":"2022041907513249300_CIT0030","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/emm.2005.6","article-title":"Leukotriene B4 pathway regulates the fate of the hematopoietic stem cells","volume":"37","author":"Chung","year":"2005","journal-title":"Exp Mol Med."},{"issue":"4","key":"2022041907513249300_CIT0031","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/carcin\/bgi026","article-title":"Increased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: a potential target for prevention","volume":"26","author":"Hoque","year":"2005","journal-title":"Carcinogenesis."},{"issue":"50","key":"2022041907513249300_CIT0032","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.1038\/sj.onc.1209666","article-title":"Endogenous production of leukotriene D4 mediates autocrine survival and proliferation via CysLT1 receptor signalling in intestinal epithelial cells","volume":"25","author":"Paruchuri","year":"2006","journal-title":"Oncogene."},{"issue":"6","key":"2022041907513249300_CIT0033","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1161\/ATVBAHA.109.185793","article-title":"Role of the low-affinity leukotriene B4 receptor BLT2 in VEGF-induced angiogenesis","volume":"29","author":"Kim","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"7","key":"2022041907513249300_CIT0034","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.4049\/jimmunol.0901735","article-title":"Proinflammatory cytokine IL-1beta stimulates IL-8 synthesis in mast cells via a leukotriene B4 receptor 2-linked pathway, contributing to angiogenesis","volume":"184","author":"Kim","year":"2010","journal-title":"J Immunol."},{"issue":"5","key":"2022041907513249300_CIT0035","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3945\/ajcn.111.030114","article-title":"Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial","volume":"95","author":"Bjermo","year":"2012","journal-title":"Am J Clin Nutr."},{"issue":"1","key":"2022041907513249300_CIT0036","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1158\/1055-9965.EPI-18-0392","article-title":"Prediagnostic serum levels of fatty acid metabolites and risk of ovarian cancer in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial","volume":"28","author":"Hada","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"2022041907513249300_CIT0037","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/978-3-030-21735-8_11","article-title":"Cytochrome P450 eicosanoid signaling pathway in colorectal tumorigenesis","volume":"1161","author":"Wang","year":"2019","journal-title":"Adv Exp Med Biol."},{"issue":"16","key":"2022041907513249300_CIT0038","doi-asserted-by":"crossref","first-page":"6530","DOI":"10.1073\/pnas.1304321110","article-title":"Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"6","key":"2022041907513249300_CIT0039","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s10552-016-0753-2","article-title":"Plasma phospholipids fatty acids, dietary fatty acids, and breast cancer risk","volume":"27","author":"Bassett","year":"2016","journal-title":"Cancer Causes Control."},{"issue":"1","key":"2022041907513249300_CIT0040","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1158\/1940-6207.CAPR-13-0261","article-title":"Effect of a low-fat fish oil diet on proinflammatory eicosanoids and cell-cycle progression score in men undergoing radical prostatectomy","volume":"7","author":"Galet","year":"2014","journal-title":"Cancer Prev Res (Phila)."},{"issue":"4","key":"2022041907513249300_CIT0041","doi-asserted-by":"crossref","first-page":"djv007","DOI":"10.1093\/jnci\/djv007","article-title":"Marine \u03c9-3 polyunsaturated fatty acids and risk of colorectal cancer according to microsatellite instability","volume":"107","author":"Song","year":"2015","journal-title":"J Natl Cancer Inst."},{"issue":"6","key":"2022041907513249300_CIT0042","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.3390\/nu12061647","article-title":"A scoping review of interactions between omega-3 long-chain polyunsaturated fatty acids and genetic variation in relation to cancer risk","volume":"12","author":"Yurko-Mauro","year":"2020","journal-title":"Nutrients."},{"issue":"2","key":"2022041907513249300_CIT0043","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/ten.teb.2008.0038","article-title":"Modulation of the inflammatory response for enhanced bone tissue regeneration","volume":"14","author":"Mountziaris","year":"2008","journal-title":"Tissue Eng Part B Rev."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgab885\/42103285\/dgab885.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgab885\/43386313\/dgab885.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgab885\/43386313\/dgab885.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T07:53:03Z","timestamp":1650354783000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/107\/5\/1383\/6460872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,14]]},"references-count":43,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,12,14]]},"published-print":{"date-parts":[[2022,4,19]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgab885","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,5,1]]},"published":{"date-parts":[[2021,12,14]]}}}